Large-scale Mendelian randomization identifies novel pathways as therapeutic targets for heart failure with reduced ejection fraction and with preserved ejection fraction
medRxiv 2024.03.22.24304728; doi: https://doi.org/10.1101/2024.03.22.24304728
Preprint
Mar 22, 2024